Pre-Market Stock Notes (JAN 16, 2007)

Photo of Douglas A. McIntyre
By Douglas A. McIntyre Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

(ALTR) Altera signed GE veteran Timothy Morse as its new CFO.
(AMTD) TD Ameritrade trading up 4% pre-market as earnings rose 13%.
(ANPI) Angiotech Pharm says its appeal to reverse a previous decision was denied.
(ARDM) Aradigm received FDA Orphan Drug Designation for Liposomal Ciprofloxacin.
(ARQL) ArQule will explore a continuous dosing schedule prior to initiation of Phase 2 testing with ARQ 197 in the second quarter of 2007 for tumor studies.
(AVR) Aventine Renewable Energy Holdings announces that Indiana Bio-Energy’s Bluffton, IN facility will join its marketing alliance network.
(BCRX) BioCryst Pharm initiates Fodosine Phase IIb clinical trial in patients with relapsed or refractory Leukemia and Lymphoma.
(BIDU) Baidu.com up 2% on pact with EMI Music for streaming music in China.
(CN) China Netcom disposes of telecommunications assets in Guangdong and Shanghai.
(CSCO) Cisco stock trading down 1.25% pre-market on Bank of America downgrade.
(CTSH) Cognizant Tech signs a 5-yr, multi-million dollar agreement with Kimberly-Clark.
(CTX) Centex lowered guidance again, now see $0.75 EPS vs $0.81 est.
(DDSS) Labopharm response to approvable letter for once-daily tramadol as complete accepted for review at the FDA.
(ELK) ElkCorp amends merger agreement with the Carlyle Group to $40.50 per share.
(EPEX) Edge Petroleum filed to sell 9.2M shares of Common Stock.
(ERJ) Embraer SA increases delivery forecast for 2007.
(ESRX) Express Scripts sets $56.87 as CVS value in share exchange.
(FTI) FMC Technologies to supply subsea systems for Woodside Energy’s Vincent project.
(GDP) Goodrich Petroleum to sell South Louisiana assets for roughly $100 million.
(GE) GE is acquiring Smiths Aerospace unit.
(HEPH) Hollis-Eden says data suggests HE3286 acts through new mechanism in Type 2 Diabetes.
(HW) Headwaters raised guidance; but filed to sell $125M in Convertible Senior Notes.
(HNAB) Hana Biosciences received orphan drug status from FDA for Mariqibo.
(KONG) KongZhong appoints new Chief Financial Officer.
(KSWS) K-Swiss shoes noted as looking cheap, but is just a value trap and therefore a Sell according to Cramer on MAD MONEY.
(MIVA) MIVA signs pay-per-click contract with Johnston Press.
(MNRO) Monroe Muffler $0.32 EPS vs $0.32 est.
(MRVC) MRV Communications up on Cramer’s “speculative stock” play.
(NDE) IndyMac substantially lowered guidance.
(NFLX) Netflix adds on online video viewing to DVD rental service plans.
(NKE) Nike touted as Best of breed over K-Swiss on Cramer’s MAD MONEY.
(NTY) NBTY preliminary revenues were $506 Million instead of $497.5 million.
(OSIR) Osiris Therapeutics receives Orphan Drug designation for PROCHYMAL in the European Union.
(PVTB) PrivateBancorp $0.42 EPS vs $0.46e.
(PWEI) J-M Manufacturing and PW Eagle announced definitive merger agreement for $33.50 per PWEI share.
(QSFT) Quest Software special committee reports findings of stock option investigation and will have charges as result of backdated options.
(RIMM) R-I-M issued additional filing regarding last Q2 and Q3 beyond last year’s filings.
(SRZ) Sunrise Senior Living has said its review is still continuing regarding a restatement
(TRCA) Tercica’s Somatuline Autogel application filing accepted by the FDA.
(VTR) Ventas making $1.8 Billion offer for Sunrise Senior Living REITR in Canada.

Photo of Douglas A. McIntyre
About the Author Douglas A. McIntyre →

Douglas A. McIntyre is the co-founder, chief executive officer and editor in chief of 24/7 Wall St. and 24/7 Tempo. He has held these jobs since 2006.

McIntyre has written thousands of articles for 24/7 Wall St. He is an expert on corporate finance, the automotive industry, media companies and international finance. He has edited articles on national demographics, sports, personal income and travel.

His work has been quoted or mentioned in The New York Times, The Wall Street Journal, Los Angeles Times, The Washington Post, NBC News, Time, The New Yorker, HuffPost USA Today, Business Insider, Yahoo, AOL, MarketWatch, The Atlantic, Bloomberg, New York Post, Chicago Tribune, Forbes, The Guardian and many other major publications. McIntyre has been a guest on CNBC, the BBC and television and radio stations across the country.

A magna cum laude graduate of Harvard College, McIntyre also was president of The Harvard Advocate. Founded in 1866, the Advocate is the oldest college publication in the United States.

TheStreet.com, Comps.com and Edgar Online are some of the public companies for which McIntyre served on the board of directors. He was a Vicinity Corporation board member when the company was sold to Microsoft in 2002. He served on the audit committees of some of these companies.

McIntyre has been the CEO of FutureSource, a provider of trading terminals and news to commodities and futures traders. He was president of Switchboard, the online phone directory company. He served as chairman and CEO of On2 Technologies, the video compression company that provided video compression software for Adobe’s Flash. Google bought On2 in 2009.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618